Literature DB >> 12067291

Immunopathogenesis of multiple sclerosis: MBP and beyond.

E Meinl, R Hohlfeld.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12067291      PMCID： PMC1906258          DOI： 10.1046/j.1365-2249.2002.01879.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  43 in total

Review 1.  Assessment of animal models for MS and demyelinating disease in the design of rational therapy.

Authors:  L Steinman
Journal:  Neuron       Date:  1999-11       Impact factor: 17.173

2.  Contribution of individual amino acids within MHC molecule or antigenic peptide to TCR ligand potency.

Authors:  B Hemmer; C Pinilla; B Gran; M Vergelli; N Ling; P Conlon; H F McFarland; R Houghten; R Martin
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

3.  Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: epitope spreading versus clonal persistence.

Authors:  N Goebels; H Hofstetter; S Schmidt; C Brunner; H Wekerle; R Hohlfeld
Journal:  Brain       Date:  2000-03       Impact factor: 13.501

4.  A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.

Authors:  L S Madsen; E C Andersson; L Jansson; M krogsgaard; C B Andersen; J Engberg; J L Strominger; A Svejgaard; J P Hjorth; R Holmdahl; K W Wucherpfennig; L Fugger
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

5.  A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosis.

Authors:  D E Goodkin; M Shulman; J Winkelhake; E Waubant; P Andersson; T Stewart; S Nelson; N Fischbein; P K Coyle; E Frohman; L Jacobs; J Holcenberg; M Lee; S Mocci
Journal:  Neurology       Date:  2000-04-11       Impact factor: 9.910

6.  Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7.

Authors:  B Bielekova; P A Muraro; L Golestaneh; J Pascal; H F McFarland; R Martin
Journal:  J Neuroimmunol       Date:  1999-12       Impact factor: 3.478

7.  Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides.

Authors:  T Tsuchida; K C Parker; R V Turner; H F McFarland; J E Coligan; W E Biddison
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

8.  In healthy primates, circulating autoreactive T cells mediate autoimmune disease.

Authors:  C P Genain; D Lee-Parritz; M H Nguyen; L Massacesi; N Joshi; R Ferrante; K Hoffman; M Moseley; N L Letvin; S L Hauser
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

9.  Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?

Authors:  M Kerschensteiner; E Gallmeier; L Behrens; V V Leal; T Misgeld; W E Klinkert; R Kolbeck; E Hoppe; R L Oropeza-Wekerle; I Bartke; C Stadelmann; H Lassmann; H Wekerle; R Hohlfeld
Journal:  J Exp Med       Date:  1999-03-01       Impact factor: 14.307

10.  Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein.

Authors:  K W Wucherpfennig; J L Strominger
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582
View more
  11 in total

Review 1.  Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain.

Authors:  Burkhard Becher; Ingo Bechmann; Melanie Greter
Journal:  J Mol Med (Berl)       Date:  2006-06-14       Impact factor: 4.599

Review 2.  B cells in autoimmune diseases: insights from analyses of immunoglobulin variable (Ig V) gene usage.

Authors:  Angela Lee Foreman; Judy Van de Water; Marie-Lise Gougeon; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2007-01-12       Impact factor: 9.754

3.  Myelin basic protein undergoes a broader range of modifications in mammals than in lower vertebrates.

Authors:  Chunchao Zhang; Angela K Walker; Robert Zand; Mario A Moscarello; Jerry Mingtao Yan; Philip C Andrews
Journal:  J Proteome Res       Date:  2012-09-21       Impact factor: 4.466

4.  The structural and functional role of myelin fast-migrating cerebrosides: pathological importance in multiple sclerosis.

Authors:  Maria Podbielska; Steven B Levery; Edward L Hogan
Journal:  Clin Lipidol       Date:  2011-04

Review 5.  Mitochondrial antigens as targets of cellular and humoral auto-immunity in primary biliary cirrhosis.

Authors:  Yasunori Ichiki; Carlo Selmi; Shinji Shimoda; Hiromi Ishibashi; Stuart C Gordon; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

Review 6.  The enigma of primary biliary cirrhosis.

Authors:  Carlo Selmi; Yasunori Ichiki; Pietro Invernizzi; Mauro Podda; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

7.  Phenytoin promotes the proliferation of oligodendrocytes and enhances the expression of myelin basic protein in the corpus callosum of mice demyelinated by cuprizone.

Authors:  Jose M Vega-Riquer; Tania Campos-Ordonez; Alma Y Galvez-Contreras; Rocío E Gonzalez-Castañeda; Oscar Gonzalez-Perez
Journal:  Exp Brain Res       Date:  2022-04-01       Impact factor: 1.972

8.  Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS.

Authors:  Doris Lambracht-Washington; Kevin C O'Connor; Elizabeth M Cameron; Andrea Jowdry; E Sally Ward; Elliot Frohman; Michael K Racke; Nancy L Monson
Journal:  J Neuroimmunol       Date:  2007-04-23       Impact factor: 3.478

9.  Kif1b is essential for mRNA localization in oligodendrocytes and development of myelinated axons.

Authors:  David A Lyons; Stephen G Naylor; Anja Scholze; William S Talbot
Journal:  Nat Genet       Date:  2009-06-07       Impact factor: 38.330

10.  Implications of Lymphocyte Anergy to Glycolipids in Multiple Sclerosis (MS): iNKT Cells May Mediate the MS Infectious Trigger.

Authors:  Edward L Hogan; Maria Podbielska; Joan O'Keeffe
Journal:  J Clin Cell Immunol       Date:  2013-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.